Synonyms |
Guanosine, 2'-C-methyl-, 5'-(2-((3-hydroxy-2,2-dimethyl-1-oxopropyl)thio)ethyl N-(phenylmethyl)phosphoramidate); 5'-O-[(Benzylamino)[2-(3-hydroxy-2,2-dimethylpropionylsulfanyl)ethoxy]phosphoryl]-2'-C-methylguanosine; 2'-C-Methylguanosine 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl N-(phenylmethyl)phosphoramidate] |
IUPAC Name |
S-[2-[[(2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-(benzylamino)phosphoryl]oxyethyl] 3-hydroxy-2,2-dimethylpropanethioate |
Molecular Weight |
626.62 |
Molecular Formula |
C25H35N6O9PS |
Canonical SMILES |
CC1(C(C(OC1N2C=NC3=C2N=C(NC3=O)N)COP(=O)(NCC4=CC=CC=C4)OCCSC(=O)C(C)(C)CO)O)O |
InChI |
InChI=1S/C25H35N6O9PS/c1-24(2,13-32)22(35)42-10-9-38-41(37,28-11-15-7-5-4-6-8-15)39-12-16-18(33)25(3,36)21(40-16)31-14-27-17-19(31)29-23(26)30-20(17)34/h4-8,14,16,18,21,32-33,36H,9-13H2,1-3H3,(H,28,37)(H3,26,29,30,34)/t16-,18-,21-,25-,41?/m1/s1 |
InChIKey |
FGHMGRXAHIXTBM-TWFJNEQDSA-N |
Purity |
≥95% |
Density |
1.59±0.1 g/cm3 |
Solubility |
Soluble in DMSO |
Appearance |
Solid Powder |
Storage |
Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) |
Complexity |
1060 |
Exact Mass |
626.19238489 |
In Vitro |
IDX184 is a liver-targeted prodrug of the nucleotide 2'-MeG-MP. IDX184 is a liver-targeted nucleotide polymerase inhibitor of hepatitis C virus. IDX184 is a second generation, orally bioavailable nucleotide prodrug designed to provide increased anti-HCV efficacy and safety versus the parent nucleoside. In HCV replicon testing, IDX184 is the most potent inhibitor (EC50=0.3-0.45 μM) compared to any of the 2' or 4' modified nucleosides (EC50=4-6 μM) and is also highly inhibitory in the JFH-1 infectious system (EC50=0.06-0.11 μM). IDX184 is not toxic (CC50>100μM) in any tested cell line. |
PSA |
259.25000 |
Target |
IC50: 0.31 μM (HCV polymerase) Ki: 52.3 nM (HCV polymerase) |
XLogP3-AA |
-1.3 |